Author: Mark DeFrance

Mark DeFrance is a senior research analyst at Tech Insider, focusing on the enterprise software sector. Prior to joining TI, Mark covered enterprise software for First Albany, and prior to that he worked in equity research at B.T. Alex Brown and Bankers Trust. Mark has written software applications in various programming languages including BASIC, Pascal, and COBOL. He has also been recognized in The Wall Street Journal's "Best on the Street" survey and was recognized by Forbes Magazine as the No. 1 sell-side stock picker in the software industry for a five-year period, with returns of 115% versus 26% for the software industry.
BioTech

Biotech active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG), Ariad Pharmaceuticals (NASDAQ:ARIA)

Bristol-Myers Squibb & Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced today that the FDA has approved an additional indication of Bristol’s anti-blood clot medicine, Eliquis. Pfizer Inc. (NYSE:PFE) stock performance was 0.35% in last session and finished the day at $31.23. Traded volume was 27.11 million shares in the last session and the average volume of the stock remained 27.87 million shares. The beta of … Continue reading Biotech active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG), Ariad Pharmaceuticals (NASDAQ:ARIA)

Mark DeFrance
BioTech

Biotech Stocks Touching New Highs: Relypsa Inc. (NASDAQ:RLYP), Vanda Pharmaceuticals (NASDAQ:VNDA), OHR Pharmaceutical (NASDAQ:OHRP), Xencor (NASDAQ:XNCR)

Relypsa, Inc. (NASDAQ:RLYP) is a pharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Relypsa Inc. (NASDAQ:RLYP) stock performance was 2.66% in last session and finished the day at $43.62. Traded volume was 126,739.00 shares in the last session and the average volume of the stock remained 113,686.00 shares. Relypsa … Continue reading Biotech Stocks Touching New Highs: Relypsa Inc. (NASDAQ:RLYP), Vanda Pharmaceuticals (NASDAQ:VNDA), OHR Pharmaceutical (NASDAQ:OHRP), Xencor (NASDAQ:XNCR)

Mark DeFrance
Finance

Money Center Banks: Bank of America Corp (NYSE:BAC), Citigroup Inc (NYSE:C), JPMorgan Chase & Co. (NYSE:JPM), Wells Fargo & Co (NYSE:WFC)

Bank of America Corp (NYSE:BAC) Merrill Lynch analysts also lowered their prediction from 7.6 per cent to 7.2 per cent for the full year due to the “significantly weaker than expected” data in the first two months. Bank of America Corp (NYSE:BAC) stock performance was -2.10% in last session and finished the day at $16.80. Traded volume was 131.30million shares in the last session and … Continue reading Money Center Banks: Bank of America Corp (NYSE:BAC), Citigroup Inc (NYSE:C), JPMorgan Chase & Co. (NYSE:JPM), Wells Fargo & Co (NYSE:WFC)

Mark DeFrance
Diversified Tech

Social Stocks In News: Facebook Inc (NASDAQ:FB), Twitter Inc (NYSE:TWTR), Yelp Inc (NYSE:YELP), Zynga Inc (NASDAQ:ZNGA)

Facebook Inc (NASDAQ:FB) Chief Executive Mark Zuckerberg blasted the U.S. government’s electronic surveillance practices on Thursday, saying he’d personally called President Barack Obama to voice his displeasure. Facebook Inc (NASDAQ:FB) stock performance was -2.89% in last session and finished the day at $68.83. Traded volume was 56,886,692 million shares in the last session and the average volume of the stock remained 64.19 million shares. Facebook … Continue reading Social Stocks In News: Facebook Inc (NASDAQ:FB), Twitter Inc (NYSE:TWTR), Yelp Inc (NYSE:YELP), Zynga Inc (NASDAQ:ZNGA)

Mark DeFrance
BioTech

Biotech Gainers: Geron Corporation (NASDAQ:GERN), Chelsea Therapeutics International (NASDAQ:CHTP), TESARO Inc (NASDAQ:TSRO), Vanda Pharmaceuticals (NASDAQ:VNDA)

Geron Corp. (NASDAQ:GERN)‘s stock had its “positive” rating reaffirmed by equities researchers at Wells Fargo & Co. in a research report issued on Thursday, AnalystRatings.NETreports. Geron Corporation (NASDAQ:GERN) stock performance was 5.62% in last session and finished the day at $1.78. Traded volume was 16,397,352 million shares in the last session and the average volume of the stock remained 5.30 million shares. The beta of … Continue reading Biotech Gainers: Geron Corporation (NASDAQ:GERN), Chelsea Therapeutics International (NASDAQ:CHTP), TESARO Inc (NASDAQ:TSRO), Vanda Pharmaceuticals (NASDAQ:VNDA)

Mark DeFrance
Services Sector

Services Sector Unusual Volume: Krispy Kreme (NYSE:KKD), Scientific Games (NASDAQ:SGMS), CTC Media (NASDAQ:CTCM), Home Inns & Hotels (NASDAQ:HMIN)

Fourth-quarter profits for Krispy Kreme (NYSE:KKD) more than tripled year over year, with the company now having approximately 800 locations worldwide. Krispy Kreme Doughnuts (NYSE:KKD) stock performance was 1.16% in last session and finished the day at $20.11. Traded volume was 5,517,121million shares in the last session and the average volume of the stock remained 1.18million shares. The beta of the stock remained 2.30. Krispy … Continue reading Services Sector Unusual Volume: Krispy Kreme (NYSE:KKD), Scientific Games (NASDAQ:SGMS), CTC Media (NASDAQ:CTCM), Home Inns & Hotels (NASDAQ:HMIN)

Mark DeFrance